openPR Logo
Press release

Gastritis Market is projected to reach USD 3.91 billion by 2034

12-11-2025 09:54 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Gastritis

Gastritis

The global Gastritis Market was valued at USD 2.34 billion in 2024 and is projected to reach USD 3.91 billion by 2034, growing at a CAGR of 5.3% during the forecast period (2025-2034). Growth is driven by rising global prevalence of Helicobacter pylori (H. pylori) infection, increasing NSAID-related gastric inflammation, rising alcohol consumption, expanding geriatric populations, and the increasing availability of advanced diagnostic tests and effective eradication therapies.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71141

Gastritis refers to acute or chronic inflammation of the stomach lining caused by infectious, autoimmune, chemical, or lifestyle-related factors. While acute gastritis often resolves with supportive care, chronic untreated gastritis can progress to peptic ulcers, gastrointestinal bleeding, or gastric cancer, underscoring the importance of early detection and treatment.

Key Market Highlights
• 2024 Market Size: USD 2.34 billion
• 2034 Forecast: USD 3.91 billion
• CAGR (2025-2034): 5.3%
• Largest Segment: H. pylori eradication therapy
• Fastest-Growing Segment: Diagnostic testing (urea breath test, stool antigen test)

Epidemiology & Clinical Insights
1. Global Burden
• H. pylori infects ~50% of the global population, making it the leading cause of chronic gastritis.
• NSAID-induced gastritis is highly prevalent in older adults.
• Autoimmune gastritis is increasingly identified due to improved diagnostics.
2. Types of Gastritis
• Acute gastritis: Usually caused by alcohol, stress, NSAIDs, or infections.
• Chronic gastritis: Primarily due to H. pylori, autoimmune disorders, or long-term irritants.
• Atrophic gastritis: Associated with increased gastric cancer risk.
3. Symptoms
• Epigastric pain
• Bloating
• Nausea/vomiting
• Indigestion
• Loss of appetite
4. Diagnostic Tools
• Endoscopy
• Urea breath test
• Stool antigen test
• Serology
• Gastric biopsy
• AI-enhanced endoscopic imaging

Market Growth Drivers
1. High Prevalence of H. pylori
Major driver of chronic gastritis requiring long-term treatment and follow-up.
2. Growing Use of NSAIDs & Aspirin
Commonly used in cardiovascular and pain management - increasing risk of gastritis.
3. Advancements in Diagnostic Testing
Non-invasive tests (UBT, stool antigen) widely adopted.
4. Development of Targeted Therapies
Dual and triple antibiotic therapies, acid suppression drugs, and bismuth-based regimens.
5. Expansion of Endoscopic Services
Early diagnosis and monitoring of gastritis and complications.

Market Restraints
• Rising antibiotic resistance reducing H. pylori eradication success
• Side effects of long-term proton pump inhibitor (PPI) usage
• Limited awareness in underserved regions
• Recurrent infections requiring repeat treatment

Market Opportunities
1. Novel H. pylori Eradication Agents
Next-generation antibiotics and antimicrobial peptides.
2. Probiotics & Microbiome Therapies
Adjunctive therapy to improve eradication rates and reduce dysbiosis.
3. AI-Assisted Diagnostic Endoscopy
Automated detection of gastritis, atrophy, and early gastric cancer.
4. Vaccines Against H. pylori (In Development)
Potential long-term preventive solution.
5. Personalized Medicine
Genotype-based therapy selection to overcome antibiotic resistance.

Segmentation Overview
By Type
• Acute gastritis
• Chronic gastritis
• Atrophic gastritis

By Cause
• H. pylori infection
• NSAID-induced
• Autoimmune
• Alcohol-related
• Stress-induced
• Others

By Treatment
• Antibiotic therapy (dual/triple/quadruple regimens)
• Proton pump inhibitors (PPIs)
• H2 blockers
• Antacids
• Probiotics
• Dietary/lifestyle interventions

By Diagnostic Method
• Upper GI endoscopy
• Urea breath test
• Stool antigen test
• Serological tests
• Biopsy

By End User
• Hospitals
• Gastroenterology clinics
• Diagnostic centers
• Retail & online pharmacies

Explore Full Report here: https://exactitudeconsultancy.com/reports/71141/gastritis-market

Regional Insights
North America - Largest Market
High NSAID use, advanced diagnostics adoption, and strong focus on early GI disease detection.
Europe - Robust Diagnostic Infrastructure
Leading countries include Germany, Italy, France, and the UK.
Asia Pacific - Fastest Growing
Highest global burden of H. pylori infection, large population, and rapid expansion of GI healthcare services.
Latin America - Emerging
Improved access to diagnostics and increasing awareness of H. pylori-related complications.
Middle East & Africa - Developing
Gradual growth due to wider availability of non-invasive tests.

Competitive Landscape
Key companies active in the gastritis therapeutics and diagnostics market include:
• Takeda Pharmaceutical
• AstraZeneca
• Bayer AG
• Pfizer
• Dr. Reddy's Laboratories
• Abbott
• GlaxoSmithKline
• Cadila Pharmaceuticals
• Eisai Co. Ltd.
• Sanofi
Focus areas include improved antibiotic regimens, acid suppression therapies, diagnostics, and microbiome-based products.

Recent Market Developments
• Increasing adoption of vonoprazan-based triple therapies
• Rising interest in probiotic adjunct therapy for H. pylori
• AI-powered endoscopic imaging rapidly improving diagnostic accuracy
• Growing clinical emphasis on managing atrophic gastritis to prevent gastric cancer

Future Outlook (2025-2034)
The Gastritis Market is expected to grow steadily as:
• H. pylori continues to drive global disease burden
• Non-invasive diagnostics become widespread
• Therapeutic regimens evolve to combat antibiotic resistance
• Probiotics and combination therapies gain traction
• GI imaging and AI improve early detection
By 2034, the market is projected to reach USD 3.91 billion, supported by strong demand for improved diagnostics and effective eradication therapies.

This report is also available in the following languages : Japanese (胃炎市場), Korean (위염 시장), Chinese (胃炎市场), French (Marché de la gastrite), German (Gastritis-Markt), and Italian (Mercato della gastrite), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/71141

Our More Reports:

Helicobacter Pylori Infections Market
https://exactitudeconsultancy.com/reports/71739/helicobacter-pylori-infections-market

Helicobacter Pylori Market
https://exactitudeconsultancy.com/reports/72885/helicobacter-pylori-market

Gastritis Treatment Market
https://exactitudeconsultancy.com/reports/51821/gastritis-treatment-market

Functional Dyspepsia Market
https://exactitudeconsultancy.com/reports/71114/functional-dyspepsia-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastritis Market is projected to reach USD 3.91 billion by 2034 here

News-ID: 4311166 • Views:

More Releases from Exactitude Consultancy

Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitation and Infrastructure Projects
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250 Key Market Highlights • Increasing focus on road maintenance and resurfacing projects • Growing demand for efficient and precision milling
Credit Management Software Market Accelerates as Organizations Focus on Risk Mitigation and Cash Flow Optimization
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248 Key Market Highlights • Growing adoption of automated credit risk assessment tools • Increasing focus on working capital and cash flow management • Integration
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Operators Strengthen Network Security
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246 Key Market Highlights • Growing adoption of VoIP and
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Traction Amid Global Decarbonization Efforts
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244 Key Market Highlights • Rapid growth of

All 5 Releases


More Releases for Gastritis

Market Analysis for Acute Gastritis Treatment 2022 to 2029
Acute Gastritis Treatment Market Highlights Global Industrial aspects of Acute Gastritis Treatment Sales Market 2023-2029: The global Acute Gastritis Treatment Market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Report Scope:- This report aims to provide a comprehensive presentation of
Gastritis Treatment Market Professional Inspection Report 2020-2027
Global Gastritis Treatment Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Gastritis Treatment Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and
Gastritis Treatment Market: Moving Towards a Brighter Future
Global Gastritis Treatment Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Gastritis Treatment Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and
Gastritis Overview - Symptoms, Types, causes and Gastritis Treatment
An Overview: Gastritis is a general term that refers to a group of conditions, each identifiable by inflammation, erosion, or irritation in the lining of the stomach. It can appear in a number of different forms, some more serious than others, and require different methods of treatment. Whether you have gastritis or not, knowing precisely what it is, what symptoms it can cause, and how to go about treating it is important
Atrophic Gastritis Global Clinical Trials Review, H1, 2017
"The Report Atrophic Gastritis Global Clinical Trials Review, H1, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Atrophic Gastritis Clinical Trials Market Summary GlobalData's clinical trial report, Atrophic Gastritis Global Clinical Trials Review, H1, 2017" provides an overview of Atrophic Gastritis clinical trials scenario. This report provides top line data relating to the clinical trials on Atrophic Gastritis. Report includes an
Gastritis Treatment Market – Global Industry Insights 2024
Gastritis is the irritation, or inflammation, or erosion of the stomach lining. Gastritis may be acute or chronic. The disease may show some symptoms or the symptoms may be dormant. Usually, the symptoms include upper abdominal pain, nausea, and vomiting. Gastritis may lead to stomach tumors, bleeding, and stomach ulcers. Gastritis is usually caused by the bacteria helicobacter pylori or by the use of nonsteroidal anti-inflammatory drugs or NSAIDs. Other